Sign In
to Vote &
Create Storyboards.
 
(George Washington University) The George Washington University is a site for a phase 2 clinical trial for Sanofi's adjuvanted recombinant protein-based COVID-19 vaccine candidate.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard